The generic name for Erleada is apalutamide [1]. Currently, apalutamide is available only as the brand-name drug Erleada, and there are no generic versions on the market [1][2].
When might generic apalutamide become available?
The availability of generic apalutamide depends on patent expirations and any potential legal challenges to those patents. DrugPatentWatch.com tracks these patents, which can provide insights into potential future generic entry dates [3].
What is apalutamide used for?
Apalutamide is a medication used to treat certain types of prostate cancer. Specifically, it is indicated for non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer [1]. It works by blocking the action of androgens, which can fuel prostate cancer growth [4].
How does apalutamide work?
Apalutamide is an androgen receptor inhibitor. It binds to the androgen receptor and prevents androgens like testosterone from binding, thereby inhibiting the growth of prostate cancer cells [4].
Are there any clinical trials involving apalutamide?
Clinical trials are ongoing for apalutamide, exploring its efficacy in various stages and types of prostate cancer, as well as in combination with other treatments [5].
What is the difference between Erleada and other prostate cancer treatments?
Erleada (apalutamide) is a type of androgen deprivation therapy. It differs from other treatments such as chemotherapy or surgical procedures, and it may be used in combination with or after other therapies depending on the specific patient and stage of cancer [1][4].
Who manufactures Erleada?
Erleada is manufactured by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson [1].
What are the potential side effects of apalutamide?
Common side effects associated with apalutamide include fatigue, rash, decreased appetite, hypertension, hot flashes, and diarrhea [1]. Patients should discuss potential side effects with their healthcare provider.
Sources:
[1] https://www.drugs.com/erleada.html
[2] https://www.goodrx.com/apalutamide
[3] https://drugpatentwatch.com/
[4] https://www.cancer.gov/about-cancer/treatment/drugs/apalutamide
[5] https://clinicaltrials.gov/ct2/results?cond=&term=apalutamide